NCT04441944 (TELEvISED) is a clinical trial of Telemedicine in Sepsis, sponsored by University of Iowa.

Who is sponsoring NCT04441944?

NCT04441944 is sponsored by University of Iowa.

What drugs are being tested in NCT04441944?

Interventions in NCT04441944: Telemedicine.

Is NCT04441944 still recruiting?

NCT04441944 is currently completed. Last updated 9 November 2022.

Last reviewed 2022-11-09 · How we verify

NCT04441944: TELEvISED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TELEmedicine as an Intervention for Sepsis in Emergency Departments

Completed Last updated 9 November 2022

What this trial tests

trial testing Telemedicine in Sepsis in 1,191 participants. Completed in 30 October 2022.

Timeline

1 August 2016

Primary endpoint
30 October 2022

30 October 2022

Quick facts

Lead sponsor	University of Iowa
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,191
Start date	1 August 2016
Primary completion	30 October 2022
Estimated completion	30 October 2022
Sites	1 location across United States

Drugs / interventions tested

Telemedicine

Conditions studied

Sepsis — all drugs for Sepsis →

Sponsor

University of Iowa

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sepsis is a life-threatening condition that has doubled in incidence over the past decade, and timely aggressive medical intervention has been shown to save lives. Rural sepsis patients have a 38% higher mortality rate, possibly attributable to delays in early sepsis care. Rural emergency department (ED)-based provider-to-provider telemedicine has been proposed to standardize care and support local clinicians in rural hospitals. The goal of this multicenter observational comparative effectiveness study is to measure the association between tele-ED use and clinical outcomes in a cohort of rural sepsis patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Outcomes Associated With Rural Emergency Department Provider-to-Provider Telehealth for Sepsis Care: A Multicenter Cohort Study.
Mohr NM, Okoro U, Harland KK, Fuller BM, et al · · 2023 · cited 10× · PMID 36253295 · DOI 10.1016/j.annemergmed.2022.07.024
TELEmedicine as an intervention for sepsis in emergency departments: a multicenter, comparative effectiveness study (TELEvISED Study).
Mohr NM, Harland KK, Okoro UE, Fuller BM, et al · · 2021 · cited 9× · PMID 33470848 · DOI 10.2217/cer-2020-0141
Provider-to-provider telemedicine for sepsis is used less frequently in communities with high social vulnerability.
Tu KJ, Vakkalanka JP, Okoro UE, Harland KK, et al · · 2025 · cited 1× · PMID 38924559 · DOI 10.1111/jrh.12861

Verify or expand the search:

Other trials of Telemedicine

Trials testing the same drug.

NCT07059884 — Distance-Based Exercise to Preserve Function and Prevent Disability · NA · recruiting
NCT07091617 — Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer · NA · recruiting
NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
NCT07124546 — Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancer · NA · recruiting
NCT06896539 — Telemedicine for Contraceptive Counselling- An Open Randomized Controlled Trial · NA · not yet recruiting

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Other University of Iowa trials

Trials by the same sponsor.

NCT07224269 — Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis · EARLY_PHASE1 · not yet recruiting
NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve · NA · recruiting
NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion · NA · recruiting
NCT06710119 — Effect of Custom Dynamic Orthoses on Forefoot Loading · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04441944 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Iowa
Last refreshed: 9 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04441944.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing